Jupiter Life Line HospitalsNSE:JLHL +0.20%69 EBITDA Margin % is 25.74% as of Mar. 2026, which is 9% above its 10-year median of 23.72. GuruFocus rates NSE:JLHL with a GF Score™ of 69/100 and a GF Value™ of ₹1,787.54 (Modestly Undervalued). Among 666 Healthcare Providers & Services companies, Jupiter Life Line Hospitals ranks better than 85.59% on this metric.
Jupiter Life Line Hospitals (NSE:JLHL) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jupiter Life Line Hospitals EBITDA Margin % Related Terms
Jupiter Life Line Hospitals EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JLHL vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Jupiter Life Line Hospitals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jupiter Life Line Hospitals EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jupiter Life Line Hospitals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jupiter Life Line Hospitals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jupiter Life Line Hospitals (NSE:JLHL) has a EBITDA Margin % of 25.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jupiter Life Line Hospitals and its competitors. This is near median its historical median of 23.72. Over the past decade, Jupiter Life Line Hospitals' EBITDA Margin % has ranged from 13.11 to 25.46. According to the industry distribution chart, Jupiter Life Line Hospitals ranks #96 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 14.4%.
Is Jupiter Life Line Hospitals' EBITDA Margin % too high?
Jupiter Life Line Hospitals' current EBITDA Margin % of 25.74% is near median its 10-year median of 23.72. Over the past 10 years, this metric has ranged from a low of 13.11 to a high of 25.46. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Jupiter Life Line Hospitals' value of 25.74% is 152.1% above this industry median. Based on the distribution chart, Jupiter Life Line Hospitals ranks #96 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jupiter Life Line Hospitals has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jupiter Life Line Hospitals' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jupiter Life Line Hospitals ranks #96 out of 666 companies for EBITDA Margin %. This places Jupiter Life Line Hospitals in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Jupiter Life Line Hospitals' value of 25.74% is 152.1% above this benchmark. Historically, Jupiter Life Line Hospitals' own EBITDA Margin % has ranged from 13.11 to 25.46 over the past decade. While the company's 10-year median is 23.72 vs. the industry median of 10.21, Jupiter Life Line Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jupiter Life Line Hospitals's current EBITDA Margin % of 25.74% is 152.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jupiter Life Line Hospitals and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jupiter Life Line Hospitals's current EBITDA Margin % is 25.74%, which is near median its own 10-year median of 23.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Life Line Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals (NSE:JLHL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,787.54, compared to a current price of ₹1,456.30 — trading 18.5% below its estimated fair value. The current EBITDA Margin % is 25.74%, which is near median its 10-year median of 23.72 and 152.1% above the Healthcare Providers & Services industry median of 10.21. Jupiter Life Line Hospitals' overall GF Score™ is 69/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jupiter Life Line Hospitals (NSE:JLHL), the current EBITDA Margin % is 25.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jupiter Life Line Hospitals (NSE:JLHL) Overvalued in 2026?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued.
The current stock price of ₹1,456.30 is trading 18.5% below its estimated GF Value™ of ₹1,787.54.
GuruFocus considers Jupiter Life Line Hospitals to be Modestly Undervalued.
Key valuation signals for NSE:JLHL:
EBITDA Margin %: 25.74% (near median its 10-year median of 23.72)
GF Value™: ₹1,787.54 vs. price of ₹1,456.30 (18.5% below fair value)
Industry Position: 152.1% above the Healthcare Providers & Services median (#96 of 666)
No single metric tells the full story. See the NSE:JLHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
69GF Score
Get the complete analysis for NSE:JLHL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JLHL has been successfully added to your 
